Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer

    NEXT STORY
    Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus COVID-19 Treatment
    PREV STORY
    CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Vir Biotechnology Appoints Janet Napolitano to its Board of Directors

    author_avatar
    NASDAQ Market News

    CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer

    author_avatar
    NASDAQ Market News

    HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020

    author_avatar
    NASDAQ Market News